Nithya Ramnath

3.5k total citations · 1 hit paper
38 papers, 2.1k citations indexed

About

Nithya Ramnath is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nithya Ramnath has authored 38 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 14 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nithya Ramnath's work include Cancer Cells and Metastasis (18 papers), Cancer Genomics and Diagnostics (12 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Nithya Ramnath is often cited by papers focused on Cancer Cells and Metastasis (18 papers), Cancer Genomics and Diagnostics (12 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Nithya Ramnath collaborates with scholars based in United States, India and South Korea. Nithya Ramnath's co-authors include Sunitha Nagrath, Max S. Wicha, Ebrahim Azizi, Diane M. Simeone, Jules Lin, Zhuo Zhang, Rishindra M. Reddy, Tae Hyun Kim, Dongfeng Tan and Fengzhi Li and has published in prestigious journals such as Journal of Clinical Oncology, Nature Nanotechnology and Cancer Research.

In The Last Decade

Nithya Ramnath

36 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets

2013 462 citations Hyeun Joong Yoon, Tae Hyun Kim et al. Nature Nanotechnology profile →

Peers

Nithya Ramnath

ONCOL

PRM

James Paget United Kingdom

Barbara Haley United States

Amy Chang United States

Chad V. Pecot United States

Henry Lin United States

D G Kieback United States

Mary Jue Xu United States

Henriëtte J.G. Arts Netherlands

Katharina Pachmann Germany

James Paget United Kingdom

Nithya Ramnath

791 ×0.7

ONCOL

587 ×0.8

518 ×0.7

397 ×0.7

399 ×1.3

PRM

Citations per year, relative to Nithya Ramnath Nithya Ramnath (= 1×) peers James Paget

Countries citing papers authored by Nithya Ramnath

Since Specialization

Citations

This map shows the geographic impact of Nithya Ramnath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nithya Ramnath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nithya Ramnath more than expected).

Fields of papers citing papers by Nithya Ramnath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nithya Ramnath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nithya Ramnath. The network helps show where Nithya Ramnath may publish in the future.

Co-authorship network of co-authors of Nithya Ramnath

This figure shows the co-authorship network connecting the top 25 collaborators of Nithya Ramnath. A scholar is included among the top collaborators of Nithya Ramnath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nithya Ramnath. Nithya Ramnath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramnath, Nithya, Prasanth Ganesan, Prasanth Penumadu, Douglas A. Arenberg, & Alex K. Bryant. (2025). Lung cancer screening in India: Preparing for the future using smart tools & biomarkers to identify highest risk individuals. The Indian Journal of Medical Research. 160(6). 561–569.

Schipper, Matthew J., Lars G. Fritsche, Garth W. Strohbehn, et al.. (2024). Pan‐Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System. Cancer Medicine. 13(21). e70379–e70379. 4 indexed citations

Zhao, Lili, Michael D. Green, Andrea Towlerton, et al.. (2024). Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer. Scientific Reports. 14(1). 345–345. 10 indexed citations

Purcell, Emma, Sarah Owen, Nithya Ramnath, et al.. (2024). Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy. Cell Reports. 43(2). 113687–113687. 7 indexed citations

Achreja, Abhinav, Noah Meurs, Olamide Animasahun, et al.. (2023). Porous PDMS‐Based Microsystem (ExoSponge) for Rapid Cost‐Effective Tumor Extracellular Vesicle Isolation and Mass Spectrometry‐Based Metabolic Biomarker Screening. Advanced Materials Technologies. 8(9). 5 indexed citations

Zhao, Lili, Michael D. Green, Andrea Towlerton, et al.. (2023). Role of HLA-DRB4 as a biomarker for endocrine toxicity and survival outcomes after immunotherapy in metastatic non-small cell lung cancer.. Journal of Clinical Oncology. 41(16_suppl). e21005–e21005. 1 indexed citations

Qin, Angel, Fatima Lima, Samantha L. Bell, et al.. (2022). Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer. Scientific Reports. 12(1). 9054–9054. 8 indexed citations

Purcell, Emma, Sarah Owen, Ting‐Wen Lo, et al.. (2021). Epidermal Growth Factor Receptor Mutations Carried in Extracellular Vesicle-Derived Cargo Mirror Disease Status in Metastatic Non-small Cell Lung Cancer. Frontiers in Cell and Developmental Biology. 9. 724389–724389. 11 indexed citations

Green, Michael D., et al.. (2021). It’s not ‘just a tube of blood’: principles of protocol development, sample collection, staffing and budget considerations for blood-based biomarkers in immunotherapy studies. Journal for ImmunoTherapy of Cancer. 9(7). e003212–e003212. 9 indexed citations

10.

Kang, Yoon‐Tae, Emma Purcell, Ting‐Wen Lo, et al.. (2020). Abstract 751: Microfluidic isolation (newExoChip) and profiling of cancer-associated exosomes using extracellular vesicular lipid-protein binding affinity. Cancer Research. 80(16_Supplement). 751–751.

11.

Owen, Sarah, Ting‐Wen Lo, Shamileh Fouladdel, et al.. (2020). Simultaneous Single Cell Gene Expression and EGFR Mutation Analysis of Circulating Tumor Cells Reveals Distinct Phenotypes in NSCLC. Advanced Biosystems. 4(8). e2000110–e2000110. 13 indexed citations

12.

Zhang, Qiang, Michael D. Green, Xueting Lang, et al.. (2019). Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy. Cancer Research. 79(15). 3940–3951. 150 indexed citations

13.

Wang, Yang, Tae Hyun Kim, Shamileh Fouladdel, et al.. (2019). PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer. Scientific Reports. 9(1). 566–566. 104 indexed citations

14.

Murlidhar, Vasudha, Rishindra M. Reddy, Shamileh Fouladdel, et al.. (2017). Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers. Cancer Research. 77(18). 5194–5206. 139 indexed citations

15.

Zhang, Zhuo, Hiroe Shiratsuchi, Nallasivam Palanisamy, Sunitha Nagrath, & Nithya Ramnath. (2016). Expanded Circulating Tumor Cells from a Patient with ALK- Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study. Journal of Thoracic Oncology. 12(2). 397–402. 38 indexed citations

16.

Zhang, Zhuo, Nithya Ramnath, & Sunitha Nagrath. (2015). Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions. Frontiers in Oncology. 5. 209–209. 52 indexed citations

17.

Ramnath, Nithya, Stephanie Daignault‐Newton, Grace K. Dy, et al.. (2013). A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 71(5). 1173–1182. 23 indexed citations

18.

Yoon, Hyeun Joong, Tae Hyun Kim, Zhuo Zhang, et al.. (2013). Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets. Nature Nanotechnology. 8(10). 735–741. 462 indexed citations breakdown →

19.

Kim, So Hee, Guoan Chen, Amanda N. King, et al.. (2012). Characterization of vitamin D receptor (VDR) in lung adenocarcinoma. Lung Cancer. 77(2). 265–271. 58 indexed citations

20.

Hernandez‐Ilizaliturri, Francisco J., et al.. (2004). Multimodality Therapy for Thymic Carcinoma (TCA). American Journal of Clinical Oncology. 27(1). 68–72. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact